PROM1 and chronic myelogenous leukemia, BCR-ABL1 positive: We found no consistent difference in the numbers or sizes of the colonies produced by either normal or CML quiescent or proliferating CD133+ or CD133− cells, although some experiments suggested enrichment of one or the other might further enhance their overall proliferative potential.